세계 임신 테스트 시장 – 2023-2030

Global Pregnancy Testing Market - 2023-2030

상품코드MDP1932
발행기관DataM Intelligence
발행일2023.10.18
페이지 수185 Pages
포맷PDF + EXCEL
커버리지Global

6,525,00011,775,000

보고서 요약(국문)

개요
글로벌 임신 테스트 시장은 2022년 YY백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) YY%로 성장하여 2030년에는 YY백만 달러에 이를 것으로 예상됩니다.
임신 테스트는 임신 중에 체내에서 생성되는 인간 융모성 고나도트로핀(HCG)이라는 호르몬을 검출합니다. 임신 테스트는 HCG를 감지하는 원리로 작동합니다. 임신 초기에는 혈중 HCG 수치가 2~3일마다 두 배로 증가하는데, 이는 임신이 진행되고 있음을 나타냅니다. 따라서 특정 수치 이상의 HCG가 검출되면 임신으로 간주됩니다.
임신 테스트에는 크게 소변 테스트와 혈액 테스트 두 가지 유형이 있습니다. 혈액 테스트는 비용이 많이 들고 소변 테스트와 결과가 유사한 경향이 있어 거의 시행되지 않습니다. 혈액 테스트는 임신 호르몬의 존재 여부뿐만 아니라 호르몬의 농도까지 확인할 수 있습니다.

시장 동향: 성장 동력 및 제약 요인
임신 테스트 키트의 기술 발전
기술 발전과 신제품 출시로 시장 성장이 촉진될 것으로 예상됩니다. 자가 임신 테스트에 대한 수요 증가 또한 시장 성장을 견인할 것으로 전망됩니다.
예를 들어, 2022년 8월 9일 호주 스타트업 후프시(Hoopsy)는 99% 종이로 만들어진 재활용 가능한 임신 테스트기를 개발하여 매년 수백만 개의 일회용 플라스틱 테스트기가 매립지로 버려지는 것을 막고자 했습니다.
2023년 2월 7일, 고품질의 효과적인 신속 테스트기 제조업체이자 유통업체인 애빙던 헬스(Abingdon Health plc)는 영국과 아일랜드 최초의 타액 기반 임신 테스트기인 살리스틱(Salistick) 출시를 위해 살리노스틱스(Salignostics)와 새로운 유통 계약을 체결했습니다. 이처럼 다양한 제품 출시가 시장 성장을 촉진할 것으로 예상됩니다.
제약 요인
위양성 결과
인지 부족과 부정확한 결과는 시장 성장을 저해하는 요인입니다. 대부분의 임신 테스트 키트는 99%의 정확도를 주장합니다. 그러나 브랜드나 잘못된 사용법 등 여러 요인에 따라 정확도가 달라지기 때문에 오진 가능성이 존재합니다.
세분화 분석
세계 임신 테스트 시장은 제품 유형, 테스트 유형, 유통 채널 및 지역별로 세분화됩니다.
임신 테스트 키트 부문은 시장 점유율의 39.5%를 차지했습니다.
임신 테스트 키트는 소변이나 혈청에서 임신 호르몬인 인간 융모성 고나도트로핀(hCG)을 검출합니다. 생리가 늦어진 첫날에 테스트를 할 수 있습니다. 임신 테스트 키트 기술의 지속적인 발전은 시장 성장을 견인할 주요 요인입니다. 전 세계적으로 계획되지 않은 임신 발생률이 증가함에 따라 임신 테스트 키트에 대한 수요가 크게 증가하고 있으며, 이는 세계 임신 테스트 시장 성장을 촉진하고 있습니다.
예를 들어, 2022년 6월 10일, Mylab Discovery Solutions는 여성이 집에서 스스로 임신 여부를 확인할 수 있는 임신 테스트 키트인 PregaScreen을 출시했습니다. 이 테스트 키트 출시로 회사는 여성 건강 관리 부문에 진출하게 되었습니다.
또한, 2022년 4월 14일, 맨카인드 파마(Mankind Pharma)의 임신 테스트 키트 브랜드는 인도 시장을 위해 새롭고 향상된 임신 감지 테스트 키트를 출시했습니다. 이 출시를 통해 회사는 임신 확인을 위한 더욱 발전된 테스트 솔루션을 지속적으로 제공하고자 노력했습니다. 이처럼 제품 출시 증가 추세는 해당 부문의 성장을 촉진할 것으로 예상됩니다.
지역 분석
북미는 전 세계 임신 테스트 시장에서 상당한 비중을 차지할 것으로 예상됩니다.
북미 지역은 2021년 가장 큰 시장 점유율을 기록했습니다. 여성들의 임신 자가 진단 키트에 대한 인식 증가, 불임 질환 증가, 계획되지 않은 임신율 증가, 신제품 출시 증가, 그리고 가족 계획 관련 정부 정책 등이 수요 증가에 기여하고 있습니다.
예를 들어, 뉴욕 타임즈의 2023년 최신 보고서에 따르면, 미국은 오랫동안 세계에서 계획되지 않은 임신율이 가장 높은 국가 중 하나였습니다. 현재 임신의 46%가 계획되지 않은 임신으로 추정됩니다.
또한, 2023년 7월 14일, 2San은 Proov와 제휴하여 미국 중서부 8개 주의 일부 Hy-Vee 매장에서 자체 개발한 사용하기 쉽고 해석하기 간편한 가정용 불임 검사 키트를 판매하기 시작했습니다. 따라서 위의 요인들이 해당 지역 시장 성장을 견인하고 있습니다.
COVID-19 영향 분석
COVID-19는 심실 보조 장치 시장에 긍정적인 영향을 미쳤습니다. 이 기간 동안 임신 테스트 키트와 불임 검사 키트의 판매량이 급증했습니다. 가정용 테스트 키트 사용 증가가 시장 성장을 촉진했습니다. 따라서 이 기간 동안 임신 테스트 시장의 성장이 증가했습니다.

경쟁 환경
상당한 시장 점유율을 차지하는 주요 기업으로는 Abbott Laboratories, BioMérieux SA, EKF Diagnostics Holdings plc, Atlas Medical, Quidel Corporation, BIOSYNEX SA, NG BIOTECH SAS, Axis Medicare, Cardinal Health Inc., Thermo Fisher Scientific Inc. 등이 있습니다.
주요 개발 사항
● 2022년 6월, Mylab Discovery Solutions는 가정용 임신 테스트 키트인 PregaScreen을 출시하여 여성들이 임신 여부를 확인할 수 있도록 했습니다.
● 2021년 3월 12일, Lia는 물에 녹는 생분해성 임신 테스트기를 출시했습니다.
보고서 ​​구매 이유

● 제품 유형, 테스트 유형, 유통 채널 및 지역별 글로벌 임신 테스트 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악하기 위해.

● 트렌드 분석 및 공동 개발을 통해 사업 기회를 식별하기 위해.

● 모든 세그먼트를 포함한 임신 테스트 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트.

● PDF 보고서는 철저한 질적 인터뷰와 심층 연구를 바탕으로 한 종합적인 분석 자료로 구성되어 있습니다.

● 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 자료는 엑셀 파일로 제공됩니다.
글로벌 임신 테스트 시장 보고서는 약 62개의 표, 59개의 그림, 그리고 185페이지 분량으로 구성됩니다.
주요 독자층 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자은행
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Pregnancy Testing Market reached US$ YY million in 2022 and is expected to reach US$ YY million by 2030, growing at a CAGR of YY% during the forecast period 2023-2030.
Pregnancy tests look for a special hormone called human chorionic gonadotropin (HCG) which is developed in a person’s body during pregnancy. Pregnancy tests work by detecting human chorionic gonadotropin (HCG). The level of HCG in the blood doubles every 2 to 3 days during the first days of pregnancy, which indicates that the pregnancy is progressing. Thus, the presence of HCG above a certain level indicates pregnancy.
There are two main types of pregnancy tests, urine tests and blood tests. Blood tests are rarely done because they’re expensive and tend to have the same result as a urine test. Blood test not only detects whether the pregnancy hormone is in the body, but can also determine how much of the hormone is present.
Market Dynamics: Drivers & Restraints
Technological advancements in pregnancy testing kits
The increase in technological advancements and the introduction of new products is expected to raise the market growth. The increase in the demand for self-pregnancy testing is expected to increase the market growth.
For instance, on August 9, 2022, Australian start-up Hoopsy created a recyclable pregnancy test that is 99 percent made out of paper, aiming to stop millions of single-use plastic versions ending up in landfill each year.
On February 7, 2023, Abingdon Health plc, manufacturer and distributor of high-quality and effective rapid tests, signed a new distribution agreement with Salignostics for the launch of Salistick the first saliva-based pregnancy test in the UK and Ireland. Thus, an increase in a variety of product launches is expected to drive the market growth.
Restraint
False positive results
Lack of awareness, and inaccurate results are hampering the market. Most of the test kits claim that they are 99% accurate. However, there is a possibility of false results, as the accuracy mainly depends on factors like the brand and improper usage.
Segment Analysis
The global pregnancy testing market is segmented based on product type, test type, distribution channel, and region.
Pregnancy test kits segment accounted for 39.5% of the market share
The pregnancy test kit detects the pregnancy hormone, human chorionic gonadotrophin (hCG), in the urine or serum. The test can be taken on the first day of the missing period. Continuous technological advancement in pregnancy test kits is a major factor expected to drive the market's growth. The demand for pregnancy test kits is increasing substantially owing to increasing incidences of unplanned pregnancies globally, driving the global pregnancy testing market.
For instance, on June 10, 2022, Mylab Discovery Solutions launched PregaScreen, an at-home pregnancy test kit that allows women to detect their pregnancy status themselves. With the launch of this test kit, the company marks its foray into the female healthcare segment.
Additionally, on April 14, 2022, Mankind Pharma’s pregnancy test kit brand launched a new and advanced pregnancy detection test kit for the Indian market. With this launch, it strived to continually provide advanced testing solutions for confirming the pregnancy. Thus, an increase in the number of product launches is expected to raise the segment growth.
Geographical Analysis
North America is expected to hold a significant position in the global pregnancy testing market share
North American region accounted for the largest market share in 2021. The increased awareness among women leads to the increased demand for self-detecting pregnancy kits, growing fertility disorders, increased unplanned pregnancy rates, increased new product launches, and favorable government initiatives related to family planning.
For instance, according to the latest report in 2023 by the New York Times, the United States has long had one of the highest rates of unintended pregnancy in the world. It is estimated that 46 percent of pregnancies are now unintended.
Additionally, on July 14, 2023, 2San partnered with Proov to distribute their proprietary easy-to-use interpret, at-home fertility tests in select Hy-Vee stores across 8 states in the Midwest. Thus, the above factors are driving the market growth in the region.
COVID-19 Impact Analysis
The COVID-19 has impacted the ventricular assist devices market positively. During this period there was a rapid increase in the sales of pregnancy kits and fertility kits. The increase in at-home test kit usage has increased the market growth. Thus, there in a rise in the pregnancy testing market growth during this period.
Competitive Landscape
The leading companies with a significant market share include Abbott Laboratories, BioMérieux SA, EKF Diagnostics Holdings plc, Atlas Medical, Quidel Corporation, BIOSYNEX SA, NG BIOTECH SAS, Axis Medicare, Cardinal Health Inc., and Thermo Fisher Scientific Inc.
Key Developments
● In June 2022, PregaScreen, introduced an at-home pregnancy test kit that enables women to determine their pregnancy status, was introduced by Mylab Discovery Solutions.
● On March 12, 2021, Lia, has introduced a flushable, biodegradable pregnancy test.
Why Purchase the Report?
● To visualize the global pregnancy testing market segmentation based on product type, test type, distribution channel and region as well as understand key commercial assets and players.
● Identify commercial opportunities by analyzing trends and co-development.
● Excel data sheet with numerous data points of pregnancy testing market-level with all segments.
● PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
● Product mapping available as excel consisting of key products of all the major players.
The global pregnancy testing market report would provide approximately 62 tables, 59 figures, and 185 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

Table of Contents
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Test Type
3.3. Snippet by Distribution Channel
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Technological advancements in pregnancy testing kits
4.1.1.2. YY
4.1.2. Restraints
4.1.2.1. False positive results
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Pregnancy Test Kits *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.3. Strips/Dipsticks and Cards
7.2.4. Digital Devices
7.2.5. Midstream Kits
7.2.6. Cassettes
7.3. Fertility Test Kits
7.3.1. Line indicator kits
7.3.2. Digital devices
7.3.3. Others
8. By Test Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
8.1.2. Market Attractiveness Index, By Test Type
8.2. HCG Blood *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. HCG Urine
8.4. FSH Urine
8.5. LH Urine
9. By Distribution Channel
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.1.2. Market Attractiveness Index, By Distribution Channel
9.2. Online Sales *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Gynecology/ Fertility Clinics
9.4. Pharmacies/Drugstores
9.5. Hypermarkets and Supermarkets
9.6. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Abbott Laboratories *
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. BioMérieux SA
12.3. EKF Diagnostics Holdings plc
12.4. Atlas Medical
12.5. Quidel Corporation
12.6. BIOSYNEX SA
12.7. NG BIOTECH SAS
12.8. Axis Medicare
12.9. Cardinal Health Inc.
12.10. Thermo Fisher Scientific Inc.
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Abbott Laboratories, 4. Key Developments, BioMérieux SA, EKF Diagnostics Holdings plc, Atlas Medical, Quidel Corporation, BIOSYNEX SA, NG BIOTECH SAS, Axis Medicare, Cardinal Health Inc., Thermo Fisher Scientific Inc.

표 목록 (Tables)

List of Tables Table 1 Global Pregnancy Testing Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)

Table 2 Global Pregnancy Testing Market Value, By Test Type, 2025, 2029 & 2033 (US$ Billion)

Table 3 Global Pregnancy Testing Market Value, By Distribution Channel, 2025, 2029 & 2033 (US$ Billion)

Table 4 Global Pregnancy Testing Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)

Table 5 Global Pregnancy Testing Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 6 Global Pregnancy Testing Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)

Table 7 Global Pregnancy Testing Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 8 Global Pregnancy Testing Market Value, By Test Type, 2025, 2029 & 2033 (US$ Billion)

Table 9 Global Pregnancy Testing Market Value, By Test Type, 2022-2033 (US$ Billion)

Table 10 Global Pregnancy Testing Market Value, By Distribution Channel, 2025, 2029 & 2033 (US$ Billion)

Table 11 Global Pregnancy Testing Market Value, By Distribution Channel, 2022-2033 (US$ Billion)

Table 12 Global Pregnancy Testing Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)

Table 13 Global Pregnancy Testing Market Value, By End-User, 2022-2033 (US$ Billion)

Table 14 Global Pregnancy Testing Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 15 Global Pregnancy Testing Market Value, By Region, 2022-2033 (US$ Billion)

Table 16 North America Pregnancy Testing Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 17 North America Pregnancy Testing Market Value, By Test Type, 2022-2033 (US$ Billion)

Table 18 North America Pregnancy Testing Market Value, By Distribution Channel, 2022-2033 (US$ Billion)

Table 19 North America Pregnancy Testing Market Value, By End-User, 2022-2033 (US$ Billion)

Table 20 North America Pregnancy Testing Market Value, By Country, 2022-2033 (US$ Billion)

Table 21 Asia-Pacific Pregnancy Testing Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 22 Asia-Pacific Pregnancy Testing Market Value, By Test Type, 2022-2033 (US$ Billion)

Table 23 Asia-Pacific Pregnancy Testing Market Value, By Distribution Channel, 2022-2033 (US$ Billion)

Table 24 Asia-Pacific Pregnancy Testing Market Value, By End-User, 2022-2033 (US$ Billion)

Table 25 Asia-Pacific Pregnancy Testing Market Value, By Country, 2022-2033 (US$ Billion)

Table 26 Europe Pregnancy Testing Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 27 Europe Pregnancy Testing Market Value, By Test Type, 2022-2033 (US$ Billion)

Table 28 Europe Pregnancy Testing Market Value, By Distribution Channel, 2022-2033 (US$ Billion)

Table 29 Europe Pregnancy Testing Market Value, By End-User, 2022-2033 (US$ Billion)

Table 30 Europe Pregnancy Testing Market Value, By Country, 2022-2033 (US$ Billion)

Table 31 South America Pregnancy Testing Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 32 South America Pregnancy Testing Market Value, By Test Type, 2022-2033 (US$ Billion)

Table 33 South America Pregnancy Testing Market Value, By Distribution Channel, 2022-2033 (US$ Billion)

Table 34 South America Pregnancy Testing Market Value, By End-User, 2022-2033 (US$ Billion)

Table 35 South America Pregnancy Testing Market Value, By Country, 2022-2033 (US$ Billion)

Table 36 Middle East and Africa Pregnancy Testing Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 37 Middle East and Africa Pregnancy Testing Market Value, By Test Type, 2022-2033 (US$ Billion)

Table 38 Middle East and Africa Pregnancy Testing Market Value, By Distribution Channel, 2022-2033 (US$ Billion)

Table 39 Middle East and Africa Pregnancy Testing Market Value, By End-User, 2022-2033 (US$ Billion)

Table 40 Middle East and Africa Pregnancy Testing Market Value, By Country, 2022-2033 (US$ Billion)

Table 41 Abbott : Overview

Table 42 Abbott : Product Portfolio

Table 43 Abbott : Key Developments

Table 44 BIOMÉRIEUX: Overview

Table 45 BIOMÉRIEUX: Product Portfolio

Table 46 BIOMÉRIEUX: Key Developments

Table 47 EKF Diagnostics Holdings plc: Overview

Table 48 EKF Diagnostics Holdings plc: Product Portfolio

Table 49 EKF Diagnostics Holdings plc: Key Developments

Table 50 Atlas Medical GmbH: Overview

Table 51 Atlas Medical GmbH: Product Portfolio

Table 52 Atlas Medical GmbH: Key Developments

Table 53 QuidelOrtho Corporation: Overview

Table 54 QuidelOrtho Corporation: Product Portfolio

Table 55 QuidelOrtho Corporation: Key Developments

Table 56 Biosynex SA: Overview

Table 57 Biosynex SA: Product Portfolio

Table 58 Biosynex SA: Key Developments

Table 59 NG Biotech: Overview

Table 60 NG Biotech: Product Portfolio

Table 61 NG Biotech: Key Developments

Table 62 Cardinal Health: Overview

Table 63 Cardinal Health: Product Portfolio

Table 64 Cardinal Health: Key Developments

Table 65 Thermo Fisher Scientific Inc.: Overview

Table 66 Thermo Fisher Scientific Inc.: Product Portfolio

Table 67 Thermo Fisher Scientific Inc.: Key Developments

Table 68 Procter & Gamble: Overview

Table 69 Procter & Gamble: Product Portfolio

Table 70 Procter & Gamble: Key Developments

그림 목록 (Figures)

List of Figures Figure 1 Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 2 Global Pregnancy Testing Market Share, By Product Type, 2024 & 2033 (%)

Figure 3 Global Pregnancy Testing Market Share, By Test Type, 2024 & 2033 (%)

Figure 4 Global Pregnancy Testing Market Share, By Distribution Channel, 2024 & 2033 (%)

Figure 5 Global Pregnancy Testing Market Share, By End-User, 2024 & 2033 (%)

Figure 6 Global Pregnancy Testing Market Share, By Region, 2024 & 2033 (%)

Figure 7 Global Pregnancy Testing Market Y-o-Y Growth, By Product Type, 2023-2033 (%)

Figure 8 Line Indicator Kits Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 9 Digital Devices Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 10 Others Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 11 Global Pregnancy Testing Market Y-o-Y Growth, By Test Type, 2023-2033 (%)

Figure 12 hCG Blood Test Test Type in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 13 hCG Urine Test Test Type in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 14 FSH Urine Test Test Type in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 15 LH Urine Test Test Type in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 16 Global Pregnancy Testing Market Y-o-Y Growth, By Distribution Channel, 2023-2033 (%)

Figure 17 Pharmacies/Drugstores Distribution Channel in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 18 Online Sales Distribution Channel in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 19 Gynecology/ Fertility Clinics Distribution Channel in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 20 Supermarkets Distribution Channel in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 21 Hypermarkets Distribution Channel in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 22 Global Pregnancy Testing Market Y-o-Y Growth, By End-User, 2023-2033 (%)

Figure 23 Home Care End-User in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 24 Hospitals End-User in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 25 Others End-User in Global Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 26 Global Pregnancy Testing Market Y-o-Y Growth, By Region, 2023-2033 (%)

Figure 27 North America Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 28 North America Pregnancy Testing Market Share, By Product Type, 2024 & 2033 (%)

Figure 29 North America Pregnancy Testing Market Share, By Test Type, 2024 & 2033 (%)

Figure 30 North America Pregnancy Testing Market Share, By Distribution Channel, 2024 & 2033 (%)

Figure 31 North America Pregnancy Testing Market Share, By End-User, 2024 & 2033 (%)

Figure 32 North America Pregnancy Testing Market Share, By Country, 2024 & 2033 (%)

Figure 33 Asia-Pacific Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 34 Asia-Pacific Pregnancy Testing Market Share, By Product Type, 2024 & 2033 (%)

Figure 35 Asia-Pacific Pregnancy Testing Market Share, By Test Type, 2024 & 2033 (%)

Figure 36 Asia-Pacific Pregnancy Testing Market Share, By Distribution Channel, 2024 & 2033 (%)

Figure 37 Asia-Pacific Pregnancy Testing Market Share, By End-User, 2024 & 2033 (%)

Figure 38 Asia-Pacific Pregnancy Testing Market Share, By Country, 2024 & 2033 (%)

Figure 39 Europe Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 40 Europe Pregnancy Testing Market Share, By Product Type, 2024 & 2033 (%)

Figure 41 Europe Pregnancy Testing Market Share, By Test Type, 2024 & 2033 (%)

Figure 42 Europe Pregnancy Testing Market Share, By Distribution Channel, 2024 & 2033 (%)

Figure 43 Europe Pregnancy Testing Market Share, By End-User, 2024 & 2033 (%)

Figure 44 Europe Pregnancy Testing Market Share, By Country, 2024 & 2033 (%)

Figure 45 South America Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 46 South America Pregnancy Testing Market Share, By Product Type, 2024 & 2033 (%)

Figure 47 South America Pregnancy Testing Market Share, By Test Type, 2024 & 2033 (%)

Figure 48 South America Pregnancy Testing Market Share, By Distribution Channel, 2024 & 2033 (%)

Figure 49 South America Pregnancy Testing Market Share, By End-User, 2024 & 2033 (%)

Figure 50 South America Pregnancy Testing Market Share, By Country, 2024 & 2033 (%)

Figure 51 Middle East and Africa Pregnancy Testing Market Value, 2022-2033 (US$ Billion)

Figure 52 Middle East and Africa Pregnancy Testing Market Share, By Product Type, 2024 & 2033 (%)

Figure 53 Middle East and Africa Pregnancy Testing Market Share, By Test Type, 2024 & 2033 (%)

Figure 54 Middle East and Africa Pregnancy Testing Market Share, By Distribution Channel, 2024 & 2033 (%)

Figure 55 Middle East and Africa Pregnancy Testing Market Share, By End-User, 2024 & 2033 (%)

Figure 56 Abbott : Financials

Figure 57 BIOMÉRIEUX: Financials

Figure 58 EKF Diagnostics Holdings plc: Financials

Figure 59 Atlas Medical GmbH: Financials

Figure 60 QuidelOrtho Corporation: Financials

Figure 61 Biosynex SA: Financials

Figure 62 NG Biotech: Financials

Figure 63 Cardinal Health: Financials

Figure 64 Thermo Fisher Scientific Inc.: Financials

Figure 65 Procter & Gamble: Financials